BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23632400)

  • 1. Oral fluoroquinolones and risk of glaucoma.
    Yang L; Etminan M; Mikelberg FS
    J Glaucoma; 2014 Sep; 23(7):464-6. PubMed ID: 23632400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of topiramate and risk of glaucoma: a case-control study.
    Etminan M; Maberley D; Mikelberg FS
    Am J Ophthalmol; 2012 May; 153(5):827-30. PubMed ID: 22265151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Oral Fluoroquinolone Use and Retinal Detachment.
    Raguideau F; Lemaitre M; Dray-Spira R; Zureik M
    JAMA Ophthalmol; 2016 Apr; 134(4):415-21. PubMed ID: 26967005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of gastrointestinal perforation in patients taking oral fluoroquinolone therapy: An analysis of nationally representative cohort.
    Hsu SC; Chang SS; Lee MG; Lee SH; Tsai YW; Lin SC; Chen ST; Weng YC; Porta L; Wu JY; Lee CC
    PLoS One; 2017; 12(9):e0183813. PubMed ID: 28873440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uveitis risk following oral fluoroquinolone therapy: a nested case-control Study.
    Forooghian F; Maberley D; Albiani DA; Kirker AW; Merkur AB; Etminan M
    Ocul Immunol Inflamm; 2013 Oct; 21(5):390-3. PubMed ID: 23876164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral fluoroquinolones and the risk of retinal detachment.
    Etminan M; Forooghian F; Brophy JM; Bird ST; Maberley D
    JAMA; 2012 Apr; 307(13):1414-9. PubMed ID: 22474205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of acute kidney injury associated with the use of fluoroquinolones.
    Bird ST; Etminan M; Brophy JM; Hartzema AG; Delaney JA
    CMAJ; 2013 Jul; 185(10):E475-82. PubMed ID: 23734036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral fluoroquinolones and risk of secondary pseudotumor cerebri syndrome: Nested case-control study.
    Sodhi M; Sheldon CA; Carleton B; Etminan M
    Neurology; 2017 Aug; 89(8):792-795. PubMed ID: 28754842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between oral fluoroquinolone use and retinal detachment.
    Pasternak B; Svanström H; Melbye M; Hviid A
    JAMA; 2013 Nov; 310(20):2184-90. PubMed ID: 24281462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Repeated Intravitreous Bevacizumab Injections With Risk for Glaucoma Surgery.
    Eadie BD; Etminan M; Carleton BC; Maberley DA; Mikelberg FS
    JAMA Ophthalmol; 2017 Apr; 135(4):363-368. PubMed ID: 28301639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review and meta-analysis of the association between systemic fluoroquinolones and retinal detachment.
    Alves C; Penedones A; Mendes D; Batel Marques F
    Acta Ophthalmol; 2016 Aug; 94(5):e251-9. PubMed ID: 26846201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk for uveitis with oral moxifloxacin: a comparative safety study.
    Eadie B; Etminan M; Mikelberg FS
    JAMA Ophthalmol; 2015 Jan; 133(1):81-4. PubMed ID: 25275293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral fluoroquinolone use and risk of peripheral neuropathy: a pharmacoepidemiologic study.
    Etminan M; Brophy JM; Samii A
    Neurology; 2014 Sep; 83(14):1261-3. PubMed ID: 25150290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoroquinolones and the risk of serious arrhythmia: a population-based study.
    Lapi F; Wilchesky M; Kezouh A; Benisty JI; Ernst P; Suissa S
    Clin Infect Dis; 2012 Dec; 55(11):1457-65. PubMed ID: 22865870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between glaucoma, glaucoma therapies, and erectile dysfunction.
    Nathoo NA; Etminan M; Mikelberg FS
    J Glaucoma; 2015 Feb; 24(2):135-7. PubMed ID: 23872619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure to oral fluoroquinolones and the risk of retinal detachment: retrospective analyses of two large healthcare databases.
    Fife D; Zhu V; Voss E; Levy-Clarke G; Ryan P
    Drug Saf; 2014 Mar; 37(3):171-82. PubMed ID: 24526267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of the association between fluoroquinolones and tendon rupture: The magnitude of the effect with and without corticosteroids.
    Persson R; Jick S
    Br J Clin Pharmacol; 2019 May; 85(5):949-959. PubMed ID: 30682225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of retinal tear or detachment with oral fluoroquinolone use: a cohort study.
    Eftekhari K; Ghodasra DH; Haynes K; Chen J; Kempen JH; VanderBeek BL
    Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):745-52. PubMed ID: 24757075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Aortic Dissection and Aortic Aneurysm in Patients Taking Oral Fluoroquinolone.
    Lee CC; Lee MT; Chen YS; Lee SH; Chen YS; Chen SC; Chang SC
    JAMA Intern Med; 2015 Nov; 175(11):1839-47. PubMed ID: 26436523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort study.
    Daneman N; Lu H; Redelmeier DA
    BMJ Open; 2015 Nov; 5(11):e010077. PubMed ID: 26582407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.